| scholarly article | Q13442814 |
| P2093 | author name string | Darren P Wallace | |
| Cibele S Pinto | |||
| Corey White | |||
| Emily Nivens | |||
| Gail A Reif | |||
| P2860 | cites work | Ca2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives | Q28239432 |
| Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells | Q28505110 | ||
| Cellular localization of type 5 and type 6 ACs in collecting duct and regulation of cAMP synthesis | Q28567878 | ||
| Gating of the cAMP signaling cascade and melatonin synthesis by the circadian clock in mammalian retina | Q28576242 | ||
| Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6) | Q28590267 | ||
| Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents | Q29615755 | ||
| The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel | Q31484726 | ||
| Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse | Q33783994 | ||
| Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. | Q33912091 | ||
| Regulation and role of adenylyl cyclase isoforms | Q33939373 | ||
| Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase | Q34019710 | ||
| Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD. | Q34212778 | ||
| Molecular biological approaches to unravel adenylyl cyclase signaling and function | Q34263887 | ||
| Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla | Q34457128 | ||
| Regulation and organization of adenylyl cyclases and cAMP. | Q34648713 | ||
| Cyclic AMP-mediated cyst expansion | Q34850793 | ||
| Calmodulin-regulated adenylyl cyclases: cross-talk and plasticity in the central nervous system | Q35073678 | ||
| Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach | Q35216906 | ||
| Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation | Q35326185 | ||
| Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells | Q35372931 | ||
| Expression and localization of the water channels in human autosomal dominant polycystic kidney disease | Q73153449 | ||
| [The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease] | Q73180314 | ||
| cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway | Q73664706 | ||
| The expression of water channels AQP1 and AQP2 in a large series of ADPKD kidneys | Q74133107 | ||
| Chloride and fluid secretion in polycystic kidney disease | Q74575440 | ||
| Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease | Q76390332 | ||
| Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist | Q79075547 | ||
| Increased water intake decreases progression of polycystic kidney disease in the PCK rat | Q79810674 | ||
| Cyclic AMP, at the hub of the cystic cycle | Q80487963 | ||
| Therapies to slow polycystic kidney disease | Q80551651 | ||
| Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells | Q81555343 | ||
| Vasopressin-2 receptor antagonists in autosomal dominant polycystic kidney disease: from man to mouse and back | Q84626176 | ||
| Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin | Q35543229 | ||
| Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice. | Q35652098 | ||
| Inhibitors of membranous adenylyl cyclases | Q35740305 | ||
| Polycystins: from mechanosensation to gene regulation | Q35839650 | ||
| AKAP (A-kinase anchoring protein) domains: beads of structure-function on the necklace of G-protein signalling | Q35922931 | ||
| Compartmentalization of adenylate cyclase and cAMP signalling | Q36295428 | ||
| Vasopressin directly regulates cyst growth in polycystic kidney disease | Q36667140 | ||
| Vasopressin antagonists in polycystic kidney disease | Q36697096 | ||
| Chloride and fluid secretion by cultured human polycystic kidney cells | Q36828895 | ||
| Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains | Q36872222 | ||
| Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor | Q36977390 | ||
| Cyclic nucleotide signaling in polycystic kidney disease | Q37051278 | ||
| G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling | Q37052266 | ||
| Functional expression of the olfactory signaling system in the kidney | Q37100981 | ||
| Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells | Q37331486 | ||
| Adenylyl cyclase--A-kinase anchoring protein complexes: the next dimension in cAMP signaling | Q37415827 | ||
| Capturing adenylyl cyclases as potential drug targets | Q37428727 | ||
| Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease. | Q37882447 | ||
| Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system | Q37950792 | ||
| Activation and inhibition of adenylyl cyclase isoforms by forskolin analogs. | Q40026894 | ||
| Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype | Q40533652 | ||
| Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. | Q40824993 | ||
| Complexity and diversity of mammalian adenylyl cyclases | Q41048221 | ||
| Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease | Q41078952 | ||
| The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease | Q42527229 | ||
| A timely characterization of vasopressin-sensitive adenylyl cyclase isoforms in the mouse inner medullary collecting duct | Q42842170 | ||
| Differential expression of adenylyl cyclases in the rat nephron | Q43725710 | ||
| Human airway smooth muscle expresses 7 isoforms of adenylyl cyclase: a dominant role for isoform V. | Q43737965 | ||
| Increased expression of adenylyl cyclase isoforms in the adrenal gland of diabetic Goto-Kakizaki rat. | Q44329653 | ||
| Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys | Q44445058 | ||
| Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic. | Q46700132 | ||
| Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. | Q46945053 | ||
| Regulation of cAMP production in initial and terminal inner medullary collecting ducts | Q47906259 | ||
| Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease. | Q51789472 | ||
| Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study. | Q52848651 | ||
| The diagnosis and prognosis of autosomal dominant polycystic kidney disease | Q68564176 | ||
| A new method for studying human polycystic kidney disease epithelia in culture | Q68979200 | ||
| Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP | Q69117270 | ||
| Expansion of extracellular volume in early polycystic kidney disease | Q69534599 | ||
| AVP-sensitive cAMP production is dependent on calmodulin in both MTAL and MCT | Q69842538 | ||
| Localization of mRNAs encoding Ca2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the cAMP content | Q71245747 | ||
| A role for CFTR in human autosomal dominant polycystic kidney disease | Q71441585 | ||
| P433 | issue | 10 | |
| P921 | main subject | autosomal dominant polycystic kidney | Q2732398 |
| P304 | page(s) | F1412-24 | |
| P577 | publication date | 2012-09-05 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells | |
| P478 | volume | 303 |
| Q55403111 | Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells. |
| Q47638249 | Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease |
| Q37524076 | Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease |
| Q39158851 | International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. |
| Q28246354 | Nedd9 restrains renal cystogenesis in Pkd1-/- mice |
| Q27011660 | Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease |
| Q27000075 | Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy |
| Q36746073 | Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease |
| Q91832389 | Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2 |
| Q91130409 | Simple renal cysts are associated with increased arterial stiffness in a Taiwanese population |
| Q26824644 | The Role of Calcium and Cyclic AMP in PKD |
| Q93134163 | The pathobiology of polycystic kidney disease from a metabolic viewpoint |
| Q40471569 | The zebrafish Kupffer's vesicle as a model system for the molecular mechanisms by which the lack of Polycystin-2 leads to stimulation of CFTR. |
| Q33660700 | Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again |
Search more.